Sanguine Biosciences, Inc.

Woburn, MA

UEI
K2BANCKDAJJ9
CAGE
7EQX5
Primary NAICS
325414 Biological Product (except Diagnostic) Manufacturing
SAM.gov registration
Active through

Company facts

Self-certified in SAM.gov
  • For Profit Organization
Entity structure
Corporate Entity (Not Tax Exempt)
SAM.gov registration date
Physical address
400 W Cummings Park suite 3050, Woburn, MA 01801, USA

Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .

Contract obligations by fiscal year

Fiscal year Obligated
FY2027 To date $0
FY2026 $100,000
FY2025 $0
FY2024 $77,705

Top agencies by obligations

Rank Agency Obligated, FY2026–FY2027 Share
1 Department of Commerce $100,000

Contract awards

Award Agency Obligated Awarded
OU63-FY26-278-new 1333ND26PNB640598 National Institute of Standards and Technology $100,000
Sanguine BIO conjunctival swab matrix prospective collection 75D30124P19767 CDC Pittsburgh $77,705
Sanguine biosciences DBA plasma 75D30121P12831 CDC Pittsburgh $108,792
Purchase human blood plasma HHSF223201510267P Food and Drug Administration $24,680

Grant awards

Quick answers

Is Sanguine Biosciences, Inc. registered in SAM.gov?

Yes. Sanguine Biosciences, Inc.'s SAM.gov registration is active through June 11, 2027.

How much has Sanguine Biosciences, Inc. received in federal contracts?

Federal contracts obligated $177,705 to Sanguine Biosciences, Inc. in fiscal years 2023 through 2027.

What is Sanguine Biosciences, Inc.'s most recent federal award?

Sanguine Biosciences, Inc.'s most recent federal contract award is OU63-FY26-278-new (1333ND26PNB640598), from National Institute of Standards and Technology, on October 1, 2026.

On GovTribe

See Sanguine Biosciences, Inc.'s full federal record

  • Federal contract awards
  • Federal grant awards
  • Funding analysis by agency, NAICS and set-aside
  • Similar vendors